The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for locally advanced or metastatic renal cell carcinoma (mRCC): phase III KEYNOTE-426 study.
 
Thomas Powles
Honoraria - Bristol-Myers Squibb; MERCK; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Ipsen
 
Elizabeth R. Plimack
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Genentech/Roche; Horizon Pharma; Incyte; Inovio Pharmaceuticals; Janssen; Merck; Novartis
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Peloton Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst); US Patent No: 15/226,474 files on 7/1/15 (Inst)
 
Viktor Stus
Research Funding - MSD; MSD (Inst)
Travel, Accommodations, Expenses - MSD
 
Rustem Airatovich Gafanov
No Relationships to Disclose
 
Robert E. Hawkins
Employment - Cellular Therapeutics; Immetacyte
Leadership - Cellular Therapeutics; Immetacyte
Stock and Other Ownership Interests - Cellular Therapeutics; Immetacyte
Honoraria - Bristol-Myers Squibb; EUSA Pharma; GlaxoSmithKline; Ipsen; Novartis; pfizer
Patents, Royalties, Other Intellectual Property - Medical Research Council - Phage Antibody Patents
 
Dmitry Nosov
Honoraria - Bristol-Myers Squibb; MSD; Pfizer
Consulting or Advisory Role - Roche
 
Frederic Pouliot
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Genzyme; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Genzyme; Janssen; Pfizer; Progenics; Sanofi
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Progenics; Sanofi
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Sanofi
Travel, Accommodations, Expenses - Bayer; Sanofi
 
Boris Yakovlevich Alekseev
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
 
Denis Soulieres
Consulting or Advisory Role - Merck
Research Funding - Merck
 
Bohuslav Melichar
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Roche
 
Ihor Vynnychenko
No Relationships to Disclose
 
Anna Kryzhanivska
No Relationships to Disclose
 
Igor Bondarenko
No Relationships to Disclose
 
Sergio Jobim Azevedo
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche
 
Delphine Borchiellini
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche
 
Qiong Shou
Employment - Merck Sharp & Dohme
 
Rodolfo F. Perini
Employment - Merck
Stock and Other Ownership Interests - Merck
Patents, Royalties, Other Intellectual Property - Application 15/101/409 (Inst)
 
Mei Chen
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Aduro Biotech; Agenus; Array BioPharma; Arrowhead Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Glactone Pharma; Iovance Biotherapeutics; Merck; Newlink Genetics/Pharmatech; Novartis; Oncolys BioPharma; Pfizer; Surface Oncology; Werewolf Pharma; X4 Pharma
 
Brian I. Rini
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche/Genentech; synthorx
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Merck; Pfizer